Tan and Tolkachjov (2024) reported that pyoderma gangrenosum lesions exhibit elevated levels of proinflammatory molecules, including various cytokines, interleukins, JAK-1, JAK-2, JAK-3, and interferon gamma. This evidence concerns the gene JAK2 and pyoderma gangrenosum.